Journal of cardiothoracic and vascular anesthesia · 2026
Preoperative Serum Raman Spectroscopy: A Rapid, Label-Free Predictor of Postoperative Pulmonary Infection After Off-Pump Coronary Artery Bypass Grafting.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hui Yuan, She Jiaman, Shi Tao, Cai Runlu, Zhang He, Guan Huaijin, Chen Qiang, Hao Junjun, Zhang Yongjian, Wang Xue, Zhu Haoyang, Wu Rongqian, Yan Yang, Zhang Zhanqin
Аннотация
OBJECTIVE: This study aimed to develop and validate a preoperative risk-stratification tool based on serum Raman spectroscopy to identify patients at high risk for postoperative pulmonary infection (PPI) following off-pump coronary artery bypass grafting (OPCABG).
DESIGN: A prospective diagnostic cohort study.
SETTING: The study was conducted at a single academic medical center.
PARTICIPANTS: A total of 276 adult patients undergoing OPCABG were enrolled. Preoperative serum samples were collected from all participants.
INTERVENTIONS: Preoperative serum was analyzed using 532 nm confocal Raman spectroscopy (400-1,800 cm-1). Participants were randomly split 7:3 into training and test sets for model development and validation.
MEASUREMENTS AND MAIN RESULTS: PPI within 72 hours was adjudicated by Centers for Disease Control and Prevention/National Healthcare Safety Network criteria. Fifty-seven patients (20.7%) developed early PPI. After feature selection via 2-sample t-test, LASSO regularization, and multivariable logistic regression, a 2-peak Raman signature (664 cm-1 and 842 cm-1) was identified. The final logistic model demonstrated strong performance on the test set, with an area under the receiver operating characteristic curve of 0.794 (95% confidence interval: 0.676-0.912), sensitivity of 70.6%, specificity of 72.7%, and a Brier score of 0.133. SHapley Additive exPlanations analysis confirmed that elevated intensities at these peaks were associated with increased early PPI risk. Decision-curve analysis indicated net clinical benefit across threshold probabilities of 15% to 35%.
CONCLUSIONS: A rapid reagent-free serum Raman signature comprising 2 peaks (664 cm-1 and 842 cm-1) provides an interpretable and effective preoperative prediction of early PPI risk in OPCABG patients, as demonstrated by internal validation.
DESIGN: A prospective diagnostic cohort study.
SETTING: The study was conducted at a single academic medical center.
PARTICIPANTS: A total of 276 adult patients undergoing OPCABG were enrolled. Preoperative serum samples were collected from all participants.
INTERVENTIONS: Preoperative serum was analyzed using 532 nm confocal Raman spectroscopy (400-1,800 cm-1). Participants were randomly split 7:3 into training and test sets for model development and validation.
MEASUREMENTS AND MAIN RESULTS: PPI within 72 hours was adjudicated by Centers for Disease Control and Prevention/National Healthcare Safety Network criteria. Fifty-seven patients (20.7%) developed early PPI. After feature selection via 2-sample t-test, LASSO regularization, and multivariable logistic regression, a 2-peak Raman signature (664 cm-1 and 842 cm-1) was identified. The final logistic model demonstrated strong performance on the test set, with an area under the receiver operating characteristic curve of 0.794 (95% confidence interval: 0.676-0.912), sensitivity of 70.6%, specificity of 72.7%, and a Brier score of 0.133. SHapley Additive exPlanations analysis confirmed that elevated intensities at these peaks were associated with increased early PPI risk. Decision-curve analysis indicated net clinical benefit across threshold probabilities of 15% to 35%.
CONCLUSIONS: A rapid reagent-free serum Raman signature comprising 2 peaks (664 cm-1 and 842 cm-1) provides an interpretable and effective preoperative prediction of early PPI risk in OPCABG patients, as demonstrated by internal validation.